These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 18766142

  • 1. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
    Masek M, Vaneckova M, Krasensky J, Danes J, Havrdova E, Hrebikova T, Seidl Z.
    Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142
    [Abstract] [Full Text] [Related]

  • 2. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M.
    Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
    [Abstract] [Full Text] [Related]

  • 3. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 4. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ.
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [Abstract] [Full Text] [Related]

  • 5. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
    Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M.
    J Neurol Sci; 2004 Aug 30; 223(2):185-93. PubMed ID: 15337621
    [Abstract] [Full Text] [Related]

  • 6. Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox?
    Strasser-Fuchs S, Enzinger C, Ropele S, Wallner M, Fazekas F.
    Mult Scler; 2008 Mar 30; 14(2):205-11. PubMed ID: 17986507
    [Abstract] [Full Text] [Related]

  • 7. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 30; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 8. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis.
    Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Morra A, Rinaldi L, Romualdi C, Perini P, Battistin L, Gallo P.
    Arch Neurol; 2007 Oct 30; 64(10):1416-22. PubMed ID: 17923625
    [Abstract] [Full Text] [Related]

  • 9. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP, Rovaris M, Comi G, Filippi M.
    Neurology; 2009 Nov 10; 73(19):1538-42. PubMed ID: 19794123
    [Abstract] [Full Text] [Related]

  • 10. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H, Yinshan Zhao, Devonshire V.
    Mult Scler; 2008 Apr 10; 14(3):314-24. PubMed ID: 18208898
    [Abstract] [Full Text] [Related]

  • 11. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
    Dalton CM, Bodini B, Samson RS, Battaglini M, Fisniku LK, Thompson AJ, Ciccarelli O, Miller DH, Chard DT.
    Mult Scler; 2012 Mar 10; 18(3):322-8. PubMed ID: 21878451
    [Abstract] [Full Text] [Related]

  • 12. Increased disability and MRI lesions after discontinuation of IFN-beta-1a in secondary progressive MS.
    Wu X, Dastidar P, Kuusisto H, Ukkonen M, Huhtala H, Elovaara I.
    Acta Neurol Scand; 2005 Oct 10; 112(4):242-7. PubMed ID: 16146494
    [Abstract] [Full Text] [Related]

  • 13. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.
    Neurology; 2007 Oct 09; 69(15):1498-507. PubMed ID: 17699802
    [Abstract] [Full Text] [Related]

  • 14. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    Arch Neurol; 2008 Feb 09; 65(2):236-43. PubMed ID: 18268194
    [Abstract] [Full Text] [Related]

  • 15. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Calabrese M, Filippi M, Rovaris M, Bernardi V, Atzori M, Mattisi I, Favaretto A, Grossi P, Barachino L, Rinaldi L, Romualdi C, Perini P, Gallo P.
    Mult Scler; 2009 Jan 09; 15(1):36-41. PubMed ID: 18755823
    [Abstract] [Full Text] [Related]

  • 16. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis.
    Vaneckova M, Seidl Z, Krasensky J, Havrdova E, Horakova D, Dolezal O, Burgetova A, Masek M.
    Eur Neurol; 2009 Jan 09; 61(5):278-84. PubMed ID: 19295214
    [Abstract] [Full Text] [Related]

  • 17. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug 09; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 18. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M, Agosta F, Sormani MP, Inglese M, Martinelli V, Comi G, Filippi M.
    Brain; 2003 Oct 09; 126(Pt 10):2323-32. PubMed ID: 12937086
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.